Salud financiera de hoja de balance de Charles River Laboratories International
Salud financiera controles de criterios 4/6
Charles River Laboratories International tiene un patrimonio de accionistas total de $3.8B y una deuda total de $2.3B, lo que sitúa su ratio deuda-patrimonio en 60.1%. Sus activos y pasivos totales son $8.0B y $4.2B respectivamente. El BAIT de Charles River Laboratories International es de $608.6M, por lo que su ratio de cobertura de intereses es de 4.9. Tiene efectivo e inversiones a corto plazo que ascienden a $210.2M.
Información clave
60.1%
Ratio deuda-patrimonio
US$2.30b
Deuda
| Ratio de cobertura de intereses | 4.9x |
| Efectivo | US$210.17m |
| Patrimonio | US$3.83b |
| Total pasivo | US$4.18b |
| Activos totales | US$8.00b |
Actualizaciones recientes sobre salud financiera
Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet
Oct 26
Charles River Laboratories International (NYSE:CRL) Takes On Some Risk With Its Use Of Debt
Jul 26Charles River Laboratories International (NYSE:CRL) Has A Pretty Healthy Balance Sheet
Mar 27Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet
Oct 27Charles River Laboratories International (NYSE:CRL) Seems To Use Debt Quite Sensibly
Jul 03Recent updates
Charles River Laboratories: Not The Right Time To Own At This Point In The Cycle
Nov 19Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet
Oct 26What Charles River Laboratories International, Inc.'s (NYSE:CRL) P/E Is Not Telling You
Oct 11Why Charles River Laboratories International, Inc. (NYSE:CRL) Could Be Worth Watching
Sep 10US$227: That's What Analysts Think Charles River Laboratories International, Inc. (NYSE:CRL) Is Worth After Its Latest Results
Aug 10Charles River Laboratories: Q2, Cost Structure Streamlining (Rating Upgrade)
Aug 10Charles River Laboratories International (NYSE:CRL) Takes On Some Risk With Its Use Of Debt
Jul 26Risks To Shareholder Returns Are Elevated At These Prices For Charles River Laboratories International, Inc. (NYSE:CRL)
Jul 11Charles River Laboratories: Fair Valuation Against Fundamentals
May 31What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?
May 25Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 30% Discount?
Apr 27Charles River Laboratories International, Inc.'s (NYSE:CRL) Price Is Out Of Tune With Earnings
Apr 11Charles River Laboratories International (NYSE:CRL) Has A Pretty Healthy Balance Sheet
Mar 27Charles River Laboratories International (NYSE:CRL) Strong Profits May Be Masking Some Underlying Issues
Feb 21Charles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold'
Feb 16Is It Time To Consider Buying Charles River Laboratories International, Inc. (NYSE:CRL)?
Jan 17Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Not Quite Adding Up
Jan 02Charles River Laboratories International (NYSE:CRL) Ticks All The Boxes When It Comes To Earnings Growth
Dec 17Charles River Laboratories: Mr. Market Went From Overvaluation To Undervaluation
Nov 26Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 29% Discount?
Nov 12Charles River: Q3 Points To Ongoing Deterioration
Nov 09Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet
Oct 27At US$197, Is Charles River Laboratories International, Inc. (NYSE:CRL) Worth Looking At Closely?
Oct 12Charles River Laboratories: Diving Into The Lab (Rating Upgrade)
Oct 06Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 27% Discount?
Aug 10Charles River Laboratories: Very Attractive After The Pullback
Jul 26Does Charles River Laboratories International (NYSE:CRL) Deserve A Spot On Your Watchlist?
Jul 22Charles River Laboratories International (NYSE:CRL) Seems To Use Debt Quite Sensibly
Jul 03When Should You Buy Charles River Laboratories International, Inc. (NYSE:CRL)?
Jun 19Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($1.5B) de CRL superan a sus pasivos a corto plazo ($1.0B).
Pasivo a largo plazo: Los activos a corto plazo ($1.5B) de CRL no cubren sus pasivos a largo plazo ($3.2B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de CRL (54.6%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de CRL ha pasado de 120.6% a 60.1% en los últimos 5 años.
Cobertura de la deuda: La deuda de CRL está bien cubierta por el flujo de caja operativo (34.6%).
Cobertura de intereses: Los pagos de intereses de la deuda de CRL están bien cubiertos por el BAIT (4.9x cobertura).